GLP1R and type 2 diabetes mellitus: Alongside lifestyle modification, oral antidiabetic drugs (OADs) with or without injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are the most usual treatment options for T2D, individualised according to the patient’s clinical status [9,11,12,13].